76
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Basic Characteristics and Survival Outcomes of Asian-American Patients with Clear Cell Renal Cell Carcinoma and Comparisons with White Patients: A Population-Based Analysis

, , , ORCID Icon &
Pages 7869-7883 | Published online: 08 Nov 2021

References

  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi:10.3322/caac.21492
  • Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol. 2010;7:245–257. doi:10.1038/nrurol.2010.46
  • Jonasch E, Walker CL, Rathmell WK. Clear cell renal cell carcinoma ontogeny and mechanisms of lethality. Nat Rev Nephrol. 2021;17:245–261. doi:10.1038/s41581-020-00359-2
  • Jonasch E, Gao J, Rathmell WK. Renal cell carcinoma. BMJ. 2014;349:g4797. doi:10.1136/bmj.g4797
  • Turajlic S, Swanton C, Boshoff C. Kidney cancer: the next decade. J Exp Med. 2018;215:2477–2479. doi:10.1084/jem.20181617
  • Krishnan B, Rose TL, Kardos J, et al. Intrinsic genomic differences between African American and white patients with clear cell renal cell carcinoma. JAMA Oncol. 2016;2:664–667. doi:10.1001/jamaoncol.2016.0005
  • Batai K, Harb-de la Rosa A, Lwin A, et al. Racial and ethnic disparities in renal cell carcinoma: an analysis of clinical characteristics. Clin Genitourin Cancer. 2019;17:e195–e202. doi:10.1016/j.clgc.2018.10.012
  • Vaishampayan UN, Do H, Hussain M, et al. Racial disparity in incidence patterns and outcome of kidney cancer. Urology. 2003;62:1012–1017. doi:10.1016/j.urology.2003.07.010
  • Berndt SI, Carter HB, Schoenberg MP, et al. Disparities in treatment and outcome for renal cell cancer among older black and white patients. J Clin Oncol. 2007;25:3589–3595. doi:10.1200/JCO.2006.10.0156
  • Chow WH, Shuch B, Linehan WM, et al. Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics. Cancer. 2013;119:388–394. doi:10.1002/cncr.27690
  • Eisenberg MS, Leibovich BC, Kim SP. Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics. Cancer. 2013;119:3100. doi:10.1002/cncr.28126
  • Wang G, Hou J, Ma L, et al. Risk factor for clear cell renal cell carcinoma in Chinese population: a case-control study. Cancer Epidemiol. 2012;36:177–182. doi:10.1016/j.canep.2011.09.006
  • Kim H, Inomoto C, Uchida T, et al. Verification of the International Society of Urological Pathology recommendations in Japanese patients with clear cell renal cell carcinoma. Int J Oncol. 2018;52:1139–1148. doi:10.3892/ijo.2018.4294
  • Liu X, Peveri G, Bosetti C, et al. Dose-response relationships between cigarette smoking and kidney cancer: a systematic review and meta-analysis. Crit Rev Oncol Hematol. 2019;142:86–93. doi:10.1016/j.critrevonc.2019.07.019
  • Nam GE, Cho KH, Han K, et al. Obesity, abdominal obesity and subsequent risk of kidney cancer: a cohort study of 23.3 million East Asians. Br J Cancer. 2019;121:271–277. doi:10.1038/s41416-019-0500-z
  • Kim CS, Han KD, Choi HS, et al. Association of hypertension and blood pressure with kidney cancer risk: a Nationwide Population-Based Cohort Study. Hypertension. 2020;75:1439–1446. doi:10.1161/HYPERTENSIONAHA.120.14820
  • Lenihan DJ, Cardinale DM. Late cardiac effects of cancer treatment. J Clin Oncol. 2012;30:3657–3664. doi:10.1200/JCO.2012.45.2938
  • Sturgeon KM, Deng L, Bluethmann SM, et al. A population-based study of cardiovascular disease mortality risk in US cancer patients. Eur Heart J. 2019;40:3889–3897. doi:10.1093/eurheartj/ehz766
  • Sanchez-Gastaldo A, Kempf E, Gonzalez Del Alba A, et al. Systemic treatment of renal cell cancer: a comprehensive review. Cancer Treat Rev. 2017;60:77–89. doi:10.1016/j.ctrv.2017.08.010
  • Nocera L, Colla Ruvolo C, Stolzenbach LF, et al. Tumor stage and substage predict cancer-specific mortality after nephrectomy for nonmetastatic renal cancer: histological subtype-specific validation. Eur Urol Focus. 2021. doi:10.1016/j.euf.2021.02.009
  • Keegan KA, Schupp CW, Chamie K, et al. Histopathology of surgically treated renal cell carcinoma: survival differences by subtype and stage. J Urol. 2012;188:391–397. doi:10.1016/j.juro.2012.04.006
  • Capitanio U, Cloutier V, Zini L, et al. A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study. BJU Int. 2009;103:1496–1500. doi:10.1111/j.1464-410X.2008.08259.x
  • Xue J, Chen W, Xu W, et al. Patterns of distant metastases in patients with clear cell renal cell carcinoma–A population-based analysis. Cancer Med. 2021;10:173–187. doi:10.1002/cam4.3596
  • Zhou Y, Zhang R, Ding Y, et al. Prognostic nomograms and Aggtrmmns scoring system for predicting overall survival and cancer-specific survival of patients with kidney cancer. Cancer Med. 2020;9:2710–2722. doi:10.1002/cam4.2916
  • Zhang G, Wu Y, Zhang J, et al. Nomograms for predicting long-term overall survival and disease-specific survival of patients with clear cell renal cell carcinoma. Onco Targets Ther. 2018;11:5535–5544. doi:10.2147/OTT.S171881
  • Zhu Y, Zhao YR, Yang XF, et al. Postoperative prognostic model for patients with clear cell renal cell carcinoma in a Chinese population. Int J Urol. 2019;26:624–629. doi:10.1111/iju.13936
  • Sims JN, Yedjou CG, Abugri D, et al. Racial disparities and preventive measures to renal cell carcinoma. Int J Environ Res Public Health. 2018;15(6):1089. doi:10.3390/ijerph15061089
  • Olshan AF, Kuo TM, Meyer AM, et al. Racial difference in histologic subtype of renal cell carcinoma. Cancer Med. 2013;2:744–749. doi:10.1002/cam4.110
  • Lipworth L, Morgans AK, Edwards TL, et al. Renal cell cancer histological subtype distribution differs by race and sex. BJU Int. 2016;117:260–265. doi:10.1111/bju.12950
  • Jivanji D, Jamieson S, Mallory C, et al. The association between race and 5-year survival in patients with clear cell renal cell carcinoma: a Cohort Study. Urology. 2021;148:185–191. doi:10.1016/j.urology.2020.10.055
  • Koene RJ, Prizment AE, Blaes A, et al. Shared risk factors in cardiovascular disease and cancer. Circulation. 2016;133:1104–1114. doi:10.1161/CIRCULATIONAHA.115.020406
  • Okwuosa TM, Anzevino S, Rao R. Cardiovascular disease in cancer survivors. Postgrad Med J. 2017;93:82–90. doi:10.1136/postgradmedj-2016-134417
  • Capitanio U, Bensalah K, Bex A, et al. Epidemiology of renal cell carcinoma. Eur Urol. 2019;75:74–84. doi:10.1016/j.eururo.2018.08.036
  • Aurilio G, Piva F, Santoni M, et al. The role of obesity in renal cell carcinoma patients: clinical-pathological implications. Int J Mol Sci. 2019;20:5683. doi:10.3390/ijms20225683
  • North BJ, Sinclair DA. The intersection between aging and cardiovascular disease. Circ Res. 2012;110:1097–1108. doi:10.1161/CIRCRESAHA.111.246876